Cargando…

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19

Detalles Bibliográficos
Autores principales:	Goshua, George, Lee, Alfred Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845060/ https://www.ncbi.nlm.nih.gov/pubmed/33537523 http://dx.doi.org/10.1002/rth2.12448

Ejemplares similares

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability
por: Zarrouk, Sinda, et al.
Publicado: (2021)

S306: HYPERCOAGULABILITY BIOMARKERS AND THROMBIN GENERATION (TG) PREDICT VENOUS THROMBOEMBOLISM (VTE) IN METASTATIC LUNG CANCER PATIENTS
por: Gomez Rosas, Patricia, et al.
Publicado: (2023)

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
por: Hoffmann, Johannes N, et al.
Publicado: (2007)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

COVID-19 and Risk of VTE in Ethnically Diverse Populations
por: Go, Alan S., et al.
Publicado: (2021)

DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices
por: Buka, Richard J., et al.
Publicado: (2022)

Development of Harmonized COVID-19 Occupational Questionnaires
por: Schlünssen, Vivi, et al.
Publicado: (2022)

Resampling and harmonization for mitigation of heterogeneity in image parameters of baseline scans
por: Singh, Apurva, et al.
Publicado: (2022)

VTE in ICU Patients With COVID-19
por: Moll, Matthew, et al.
Publicado: (2020)

CLOTTING AND COVID-19: IT IS NOT ALWAYS VTE
por: LINK, STEPHANIE L, et al.
Publicado: (2022)

Indicators of hypercoagulability and recurrent venous thromboembolism in the elderly: rethinking age and thrombophilia
por: Middeldorp, Saskia
Publicado: (2023)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

VTE in ICU: Lessons from COVID-19
por: Chu, Xu, et al.
Publicado: (2022)

Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients
por: Roubinian, Nareg H., et al.
Publicado: (2023)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

COVID-19 Associated 60-Day Acute VTE Events in Hospitalized Patients Can be Predicted By D-Dimer and Prior VTE but Not By Reticulated Platelets
por: Ashraf, Bilal, et al.
Publicado: (2022)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
por: Jiang, Mingshan, et al.
Publicado: (2021)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

VTE PROPHYLAXIS STRATEGIES WITH ENOXAPARIN DURING THE COVID-19 PANDEMIC
por: MARK NGUYEN, HUAN, et al.
Publicado: (2021)

No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study
por: Delrue, Maxime, et al.
Publicado: (2022)

Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry
por: Ohashi, Yasuo, et al.
Publicado: (2020)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review)
por: Zhang, Shuoqi, et al.
Publicado: (2021)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

Long lasting hypercoagulability after subclinical COVID-19
por: Ferroli, Paolo, et al.
Publicado: (2020)

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

Clinical Features and Management of COVID-19–Associated Hypercoagulability
por: Massaro, Gianluca, et al.
Publicado: (2022)

Hypercoagulability of COVID-19 and Neurological Complications: A Review
por: Moore, Patrick, et al.
Publicado: (2022)

COVID-19-Induced Hypercoagulability: A Case Report
por: Sperry, Bailey, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b6cd1gloansvr537vft0m53u99